Cargando…

Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors

A series of novel benzohydrazide derivatives containing dihydropyrazoles have been synthesized as potential epidermal growth factor receptor (EGFR) kinase inhibitors and their biological activities as potential antiproliferative agents have been evaluated. Among these compounds, compound H20 exhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hai-Chao, Yan, Xiao-Qiang, Yan, Tian-Long, Li, Hong-Xia, Wang, Zhong-Chang, Zhu, Hai-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273578/ https://www.ncbi.nlm.nih.gov/pubmed/27527130 http://dx.doi.org/10.3390/molecules21081012

Ejemplares similares

Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation
por: Yan, Xiao-Qiang, et al.
Publicado: (2019)

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
por: Al-Warhi, Tarfah, et al.
Publicado: (2022)

Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives
por: Shaik, Afzal, et al.
Publicado: (2020)

New azobenzene liquid crystal with dihydropyrazole heterocycle and photoisomerization studies
por: Wang, Xiaoxuan, et al.
Publicado: (2020)

Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity
por: Eldehna, Wagdy M., et al.
Publicado: (2022)

Design, Synthesis, and In Vitro Evaluation of Novel Indolyl DiHydropyrazole Derivatives as Potential Anticancer Agents
por: Venugopala, Katharigatta N., et al.
Publicado: (2021)

Design, Facile Synthesis and Characterization of Dichloro Substituted Chalcones and Dihydropyrazole Derivatives for Their Antifungal, Antitubercular and Antiproliferative Activities
por: Shaik, Afzal B., et al.
Publicado: (2020)

Design, synthesis and biological evaluation of a series of dianilinopyrimidines as EGFR inhibitors
por: Yan, Longjia, et al.
Publicado: (2022)

Direct N-heterocyclization of hydrazines to access styrylated pyrazoles: synthesis of 1,3,5-trisubstituted pyrazoles and dihydropyrazoles
por: Venkateswarlu, Vunnam, et al.
Publicado: (2018)

3D-QSAR Studies of Dihydropyrazole and Dihydropyrrole Derivatives as Inhibitors of Human Mitotic Kinesin Eg5 Based on Molecular Docking
por: Luo, Xingyan, et al.
Publicado: (2012)

1-[5-(3,4-Dichlorophenyl)-3-(2-naphthyl)-4,5-dihydropyrazol-1-yl]ethanone
por: Lu, Zhi-Ke, et al.
Publicado: (2008)

N′-(2-Hydroxybenzylidene)-2-methoxybenzohydrazide monohydrate
por: Lu, Jiu-Fu, et al.
Publicado: (2008)

4-Chloro-N′-(2-hydroxybenzylidene)benzohydrazide monohydrate
por: Lu, Jiu-Fu, et al.
Publicado: (2008)

2-Methoxy-N′-(2-methoxybenzylidene)benzohydrazide
por: Lu, Jiu-Fu, et al.
Publicado: (2008)

Dihydropyrazole Derivatives Act as Potent α-Amylase Inhibitors and Free Radical Scavengers: Synthesis, Bioactivity Evaluation, Structure–Activity Relationship, ADMET, and Molecular Docking Studies
por: Ali, Arif, et al.
Publicado: (2023)

Chronicles of EGFR Tyrosine Kinase Inhibitors: Targeting EGFR C797S Containing Triple Mutations
por: Duggirala, Krishna Babu, et al.
Publicado: (2022)

Formal [4 + 1] cycloaddition of in situ generated 1,2-diaza-1,3-dienes with diazo esters: facile approaches to dihydropyrazoles containing a quaternary center
por: Chen, Bo, et al.
Publicado: (2019)

Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors
por: Hu, Xiuqin, et al.
Publicado: (2017)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
por: El-Sayed, Magda A.-A., et al.
Publicado: (2017)

N-(4-Fluorobenzoyl)-2-hydroxy-4-methylbenzohydrazide
por: Feng, Hai-Mei, et al.
Publicado: (2008)

Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
por: Le, Yi, et al.
Publicado: (2020)

N′-(2-Chlorobenzylidene)-4-methylbenzohydrazide
por: Wang, De-Cheng, et al.
Publicado: (2012)

Novel Inhibitors of Acetyl- and Butyrylcholinesterase Derived from Benzohydrazides: Synthesis, Evaluation and Docking Study
por: Houngbedji, Neto-Honorius, et al.
Publicado: (2023)

N′-(2-Methoxybenzylidene)-4-nitrobenzohydrazide
por: Zhu, Hai-Yun
Publicado: (2011)

Synthesis of kinase inhibitors containing a pentafluorosulfanyl moiety
por: Sansook, Supojjanee, et al.
Publicado: (2017)

N′-(Furan-2-ylmethylene)-2-hydroxybenzohydrazide
por: Zhang, Yan-Xia
Publicado: (2008)

N′-(2,4-Dichlorobenzylidene)-2-fluorobenzohydrazide
por: Wang, Hai-Tao, et al.
Publicado: (2011)

Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6
por: Balbuena-Rebolledo, Irving, et al.
Publicado: (2022)

3-Chloro-N′-[(2-methoxynaphthalen-1-yl)methylidene]benzohydrazide
por: Li, Tian-Yi, et al.
Publicado: (2011)

3-Hydroxy-N′-(2-hydroxybenzylidene)benzohydrazide
por: Peng, San-Jun, et al.
Publicado: (2008)

Design, synthesis and antibacterial potential of 5-(benzo[d][1,3]dioxol-5-yl)-3-tert-butyl-1-substituted-4,5-dihydropyrazoles
por: El-Behairy, Mohammed F., et al.
Publicado: (2015)

Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling
por: Mahalapbutr, Panupong, et al.
Publicado: (2022)

Correction: Synthesis of kinase inhibitors containing a pentafluorosulfanyl moiety
por: Sansook, Supojjanee, et al.
Publicado: (2017)

Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors
por: Khan, Nashrah Sharif, et al.
Publicado: (2020)

Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
por: Zhong, Hua, et al.
Publicado: (2023)

Synthesis, in silico studies and biological screening of (E)-2-(3-(substitutedstyryl)-5-(substitutedphenyl)-4,5-dihydropyrazol-1-yl)benzo[d]thiazole derivatives as an anti-oxidant, anti-inflammatory and antimicrobial agents
por: Kumar, Manoj, et al.
Publicado: (2022)

Targeting EGFR Tyrosine Kinase: Design, Synthesis and Biological Evaluation of Novel Quinazolinone Derivatives
por: Nematpour, Manijeh, et al.
Publicado: (2022)

(E)-N′-(4-Methoxybenzylidene)benzohydrazide
por: Gou, Jian-Xia, et al.
Publicado: (2009)

Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease
por: Yan, Ning, et al.
Publicado: (2022)

Formation of 1-(thiazol-2-yl)-4,5-dihydropyrazoles from simple precursors: synthesis, spectroscopic characterization and the structures of an intermediate and two products
por: Mahesha, Ninganayaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hh3i3vieaaqg0p29gsqb9l8qic